Trial intelligence / Profile preview

Bronchiolitis Endotracheal Surfactant Study

ISRCTN11746266Phase 2Active, not recruiting

Sponsor
University of Liverpool
Start
Nov 2018
Modality
Recombinant Proteins and Enzymes
01

Overview

Phase 2, randomised, double-blind trial in bronchiolitis comparing Poractant alfa with Air placebo (2 arms). Primary endpoint: Total duration of mechanical ventilation. Started Nov 2018; status: active, not recruiting.

02

Drugs

Poractant alfa
03

Conditions

bronchiolitis

Beyond the preview

Go deeper on ISRCTN11746266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN11746266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call